HQL (HQL)
Invests in biotech, pharmaceutical, and healthcare companies worldwide, focusing on smaller growth stocks.
$19.37+0.00%Financial Services
StockGlow Score
Bullish
BearishBullish
1 year ago+47.6%
The outlook
HQL is trading above both its 50- and 200-day moving averages, positioning it in the upper half of its 52-week range. The stock carries a very low trailing P/E of 2.9. Analyst coverage appears limited, so specific rating data isn't available here.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range77% of the way from its 52-week low to high
Market cap
—
52-wk high
$21.32
52-wk low
$13.01
50-day avg
$18.53
200-day avg
$17.36
Trailing P/E
2.9